European Migraine Day of Action with MEPS in the European Parliament

2019-09-14T19:11:32+00:0012/09/2019|Categories: News|

Each year, September 12th is the International Migraine Day of Action. Today, EMHA’s President and Executive Director have been invited by MEP Esteban Gonzalez Pons and MEP Dolors Montserrat to the European Parliament to discuss about how to better help the affected ones to give light to the disease and how to improve the life of the affected ones. Migraine is a chronic disease which negatively influences patients’ lives and their ability to fully integrate within society. About 15% of the European population has to deal with this neurological disease . It means that in average, in your country, 1 [...]

New drugs, decades in the making, are providing relief for migraines.

2018-12-11T12:47:38+00:0011/12/2018|Categories: New Treatment, News|Tags: , , |

Nancy Baum Lipsitz remembers the night the pain began. She’d had a glass of white wine with a friend and went to bed with a terrible headache. The next day, she still felt horrible, the beginning of what she called a “rolling tide” of near constant migraines and lower level headaches. For three years she dealt with the symptoms. Sometimes she got tunnel vision, or a visual aura, a warning that a big headache was on the way. Those felt like “someone taking a pick and jabbing it through my nose and eye,” she said. Then there was the vomiting, [...]

YOGA AND MIGRAINE

2018-12-05T12:31:18+00:0005/12/2018|Categories: News|Tags: , , , , , |

What Can Yoga Do for Migraine Relief? Yoga can provide more than just physical fitness. It can bring calm and peace to your mind and body, as well as help with ailments such as anxiety, depression, and pain. It isn’t clear exactly how yoga changes the body in this manner, though the parasympathetic nervous system (PNS) may play a role. During yoga, the PNS can slow your heart rate and lower your blood pressure. This allows your body to recover after a stressful event, such as a migraine. Not only is yoga a holistic approach to fighting migraines as they’re [...]

“Green light” to Lilly’s monoclonal antibody to migraine

2018-11-28T17:21:25+00:0028/11/2018|Categories: Industry, News|Tags: , , , , , , , |

Eli Lilly announces that the European Commission (EC) has approved the commercialization of galcanezumab ( Emgality ) as a prophylactic treatment of migraine in adults suffering from at least four days of migraine per month . Galcanezumab is a humanized monoclonal antibody that binds to the peptide related to the calcite gene (CGRP, for its acronym in English) associated with episodes of migraine, blocks its function Administered with a month subcutaneous injection which can be applied to the patient with a pen or pre-filled syringe. In all three clinical trials, galcanezumab has shown significantly reducing the monthly average of migraine days and an improvement in functionality versus placebo. "Migraine is [...]

Migraine Atlas by AEMICE

2018-11-14T19:06:40+00:0014/11/2018|Categories: News|Tags: , , |

AEMICE together with Universidad de Sevilla (Seville University) and Novartis and a scientific committee of expert neurologists has created the "Migraine Atlas 2018" which reflects the real situation of the 4.5 million people who suffer from migraine in Spain! Unlike other studies "Migraine Atlas" includes the patients and also their families perspective about their condition, the healthcare system, effectivity of treatments, psicological aspects, limitations within their social lives, at the workplace, at home, self-medication and or fears and hopes, all these collected through questionnaire done to more than 2.500 people with migraine. Moreover, the inform shows an analysis of the scientific lecture and other [...]

Congratulations Kalina!!

2018-11-09T14:01:03+00:0009/11/2018|Categories: Events, News|Tags: , , , |

We would like to give the warmest and biggest congratulations to our Board Officer and Cluster Headache Delegate, Kalina Tyminski!!! We are beyond proud to announce that Mrs. Tyminski just received a Certificate of Commendation for Young Volunteer Advocate from the EFNA Advocacy Awards 2018.  Thank you for all your hard work, dedication, outstanding contribution and always enormous effort for our cause. Keep the great work!

Master of Headache Disorder

2018-10-26T14:01:11+00:0026/10/2018|Categories: News|Tags: , , |

Copenhagen University is now offering a Master on Headache Disorders. It´s a continuing professional development programme for healthcare professionals. The programme requires a minimum of 6 individual visits to Copenhagen, Denmark over a two-year period: Modules 1 to 4 are organized with an e-learning self-study period followed by one week of face-to-face sessions at University of Copenhagen. Module 5 is a three week clinical course at the Danish Headache Centre. Module 6 is the final module. This module is comprised of a master’s thesis, which is completed with an oral examination in Denmark. This medical master’s programme consists of modules covering headache [...]

Migraine Association of Ireland

2018-10-19T12:26:46+00:0019/10/2018|Categories: Associations, Events, News|Tags: , , |

Migraine Awareness Week 2018 MAI held an accredited Health Care Professional Seminar, during which two international speakers presented on Migraine: Diagnosis and Treatment, and the Development of the new Anti-CGRP medication. Prof. Lars Edvinsson and Prof. Allan Purdy, both members of the IHS, followed this up by doing a webinar for members of the Irish Pharmacy Union In conjunction with this, MAI has been running a campaign ‘A Headache a Day is not Okay’ to encourage migraineurs to consult with their pharmacist regarding medication and treatment for migraine, while avoiding Medication Overuse Headache. MAI is also encouraging pharmacists to build [...]

#MoveForMigraine

2018-10-18T12:00:15+00:0018/10/2018|Categories: Associations, News|Tags: , |

#MoveForMigraine Migraine remains an overlooked and misunderstood condition in many parts of Europe, including Belgium. The disease suffers from a lack of recognition and understanding, even from the first concerned parties (patients, caregivers, employers, etc.). This comes at a significant burden for the patients and at a high cost for society (1,650,000 working days lost every year in Belgium). #Move4Migraine is an independent, multidisciplinary platform that brings patients and actors from the healthcare, labour world and civil society together. Mik Ver Berne, chair of the Belgian Headache Association and member of the European Migraine Headache Alliance (EMHA), participates in the [...]

We and our partners use cookies, to collect browsing data to give you the best online experience and to personalize the content, play multimedia content, interact with social networks and perform browsing analytics. If you continue browsing we understand you accept the use of such technology. For more information visit our cookies policy Find out more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close